Watanabe et al., Exp. Cell Res., 183, 1989, 335-342.* |
Akinaga et al., Cancer Chemother., Pharmol., 1993, 32:183-189.* |
Hallahan et al., Radiation Res., vol. 129, No. 3, 1992, 345-350.* |
Waddick et al., Radiation Res., vol. 136, 313-319, 1993.* |
Crompton et al., vol. 135, No. 3, 1993, 372-379.* |
Kim et al., Br. J. Cancer., 1992, 66, 844-849.* |
Saad et al., J. of Cellular Physiology, 161:142-148, 1994.* |
Kharbanda et al., T. of Biol. Chem., vol. 269, No. 32, 20739-20743, 1994.* |
Kharbanda et al., Oncogene, 1994, 9, 3005-3011.* |
Kitamura, Y. et al., Acta Histochem. Cytochem., vol. 27(1), pp. 17-22, 1994.* |
Brach et al., “Ionizing Radiation Induces Expression and Binding Activity of the Nuclear Factor κB,” J. Clin. Invest., 88:691-695, 1991. |
Cantley et al., “Oncogenes and Signal Transduction,” Cell, 64:281-302, 1991. |
Datta et al., “Involvement of Reactive Oxygen Intermediates in the Induction of c-jun Gene Transcription by Ionizing Radiation,” Biochemistry, 31(5):8300-8306, 1992. |
Enoch and Nurse, “Mutation of the Fission Yeast Cell Cycle Control Genes Abolishes Dependence of Mitosis on DNA Replication,” Cell, 60:665-673, 1990. |
Gould et al., “Complementation of the Mitotic Activator, p80cdc25, by a Human Protein-Tyrosine Phosphatase,” Science, 250:1573-1576, 1990. |
Hallahan et al., “Molecular Basis for the Use of Glucocorticoids, Nonsteroidals and Pentoxifylline to Minimize the Acute Effects of Radiotherapy,” Cancer Research, 51:4565-4569, 1991. |
Hallahan et al., “Increased tumor necrosis factor α mRNA after cellular exposure to ionizing radiation,” Proc. Natl. Acad. Sci. USA, 86:10104-10107, 1989. |
Hallahan et al., “Transcriptional regulation of the TNF gene by x-irradiation,” Proc. Am. Assoc. Cancer Res., 31(0):75, 1990. |
Hallahan et al., “Protein kinase C mediates x-ray inducibility of nuclear signal transducers EGR1 and JUN,” Proc. Natl. Acad. Sci. USA, 88:2156-2160, 1991. |
Hallahan et al., “Tumor Necrosis Factor Gene Expression Is Mediated by Protein Kinase C following Activation by Ionizing Radiation,” Cancer Research, 51:4565-4569, 1991. |
Hallahan et al., “Ketoconazole Attenuates Radiation-Induction of Tumor Necrosis Factor,” J.J. Radiation Oncology, in press, 1994. |
Hallahan et al., “Mechanisms of X-Ray Mediated Protooncogene c-jun Expression in Radiation-Induced Human Sarcoma Cell Lines,” Int. J. Radiation Oncology Biol. Phys., 21(6):1677-1681, 1991. |
Hartwell and Weinert, “Checkpoints: Controls That Ensure the Order of Cell Cycle Events,” Science, 246:629-634, 1989. |
Hollander and Fornace, “Induction of fos RNA by DNA-damaging Agents,” Cancer Research, 49:1687-1692, 1989. |
Kastan et al., “Participation of p53 Protein in the Cellular Response to DNA Damage,” Cancer Research, 51:6304-6311, 1991. |
Lambert and Borek, “X-ray-Induced Changes in Gene Expression in Normal and Oncogene-Transformed Rat Cell Lines,” Journal of the National Cancer Institute, 80(18):1492-1497, 1988. |
Mustelin and Altman, “Dephosphorylation and activation of the T cell tyrosine kinase pp561ck by the leukocyte common antigen (CD45),” Oncogene, 5:809-813, 1990. |
Neta et al., “Role of Interleukin 6 (IL-6) in Protection from Lethal Irradiation and in Endocrine Responses to IL-1 and Tumor Necrosis Factor,” The Journal of Experimental Medicine, 175:689-694, 1992. |
Nurse, “Universal control mechanism regulating onset of M-phase,” Nature, 344:503-508, 1990. |
Papathanasiou et al., “Identification of an x-ray-inducible human gene and its altered expression in ataxia telangiectasia,” Proceedings of the American Association for Cancer Research, 31:304, 1990. |
Pleiman et al., “Mapping of Sites of the Src Family Protein Tyrosine Kinase p55blk, p59fyn, and p56lyn Which Interact with the Effector Molecules Phospholipase C-γ, Microtubule-Associated Protein Kinase, GTPase-Activating Protein, and Phosphatidylinositol 3-Kinase,” Molecular and Cellular Biology, 13(9):5877-5887, 1993. |
Sherman et al., “Ionizing radiation regulates expression of the c-jun protooncogene,” Proc. Natl. Acad. Sci. USA, 87:5663-5666, 1990. |
Uckun et al., “Tyrosine phosphorylation is a mandatory proximal step in radiation-induced activation of the protein kinase C signaling pathway in human B-lymphocyte precursors,” Proc. Natl. Acad. Sci. USA, 90:252-256, 1993. |
Uckun et al., “Ionizing radiation stimulates unidentified tyrosine-specific protein kinases in human B-lymphocyte precursors, triggering apoptosis and clonogenic cell death,” Proc. Natl. Acad. Sci. USA, 89:9005-9009, 1992. |
Weichselbaum et al., “Radiation-resistant and repair-proficient human tumor cells may be associated with radiotherapy failure in head- and neck-cancer patients,” Proc. Natl. Acad. Sci. USA, 83:2684-2688, 1986. |
Weichselbaum et al., “X-Ray Sensitivity of Fifty-three Human Diploid Fibroblast Cell Strains from Patients with Characterized Genetic Disorders,” Cancer Research, 40:902-925, 1980. |
Yamanashi et al., “Activation of Src-like protein-tyrosine kinase Lyn and its association with phosphatidylinositol 3-kinase upon C-cell antigen receptor-mediated signaling,” Proc. Natl. Acad. Sci. USA, 89:1118-1122, 1992. |
Abou-Shoer et al., Flavonoids from Koelreuteria Henryi And Other Sources As Protein-Tyrosine Kinase Inhibitors, J. Nat. Proc., 56(6):967-9, 1993. |
Atherton-Fessler et al., “Mechanisms of p34cdc2 Regulation,” Molecular and Cellular Biology, 13(3):1675-1685, 1993. |
Al-Khodiary and Carr, DNA repair mutants defining G2 checkpoint pathways in Schizosaccharomyces pombe, The EMBO Journal, 11(4):1343-1350, 1992. |
Barbet and Carr, “Fission yeast wee1 protein kinase is not required for DNA damage-dependent mitotic arrest,” Nature, 364:824-827, 1993. |
Bhuyan et al., “Lethality, DNA Alkylation and Cell Cycle Effects of Adozelesin (U-73975) on Rodent and Human Cells,” Cancer Research, 52:5687-5692, 1992. |
Bonni et al., “Characterization of a Pathway for Ciliary Neurotrophic Factor Signaling to the Nucleus,” Science, 262:1575-1579, 1993. |
Buchdunger et al., “4,5-Dianilinophthalimide: A protein-tyrosine kinase inhibitor with selectivity for the epidermal growth factor receptor signal transduction pathway and potent in vivo antitumor activity,” Proc. natl. Acad. Sci. USA, 91:2334-2338, 1994. |
Carter et al., “Tyrosine phosphorylation of phospholipase C induced by membrane immunoglobulin in B lymphocytes,” Proc. Natl. Acad. Sci. USA, 88:2745-2749, 1991. |
Casillas et al., “Stimulation of B-cells via the Membrane Immunoglobulin Receptor or with Phorbol Myristate 13-Acetate Induces Tyrosine Phosphorylation and Activation of a 42-kDa Microtubule-associated Protein-2 Kinase,” The Journal of Biological Chemistry, 266(28):19088-19094, 1991. |
Chan et al., “Selective inhibition of the growth of ras-transformed human bronchial epithelial cells by emodin, a protein-tyrosine kinase inhibitor,” Biochemical and Biophysical Research Communications, 193(3):1152-1158, 1993. |
Chen et al., “Structure of malhamensilipin A, an inhibitor of protein tyrosine kinase, from the cultured chrysophyte poterioochromonas malhamensis,” Journal of Natural Products, 57(4):524-527, 1994. |
Datta et al., “Ionizing radiation activates transcription of the EGR1 gene via CArG elements,” Proc. Natl. Acad. Sci. USA, 80:10149-10153, 1992. |
Datta et al., “Reactive oxygen intermediates target CC(A/T)6GG sequences to mediate activation of the early growth response 1 transcription factor gene by ionizing radiation,” Proc. Natl. Acad. Sci. USA, 90:2419-2422, 1993. |
Desai et al., “Activation of Human Cyclin-Dependent Kinase In Vitro,” Molecular Biology of the Cell, 3:571-582, 1992. |
Devary et al., “The Mammalian Ultraviolet Response is Triggered by Activation of the Src Tyrosine Kinases,” Cell, 71:1081-1091, 1992. |
Gillespie et al., “Inhibition of pancreatic cancer cell growth in vitro by the tyrphostin group of tyrosine kinase inhibitors,” Br. J. Cancer, 68:1122-1126, 1993. |
Gold et al., “Membrane Ig Cross-Linking Regulates Phosphatidylinositol 3-Kinase In B Lymphocytes,” The Journal of Immunology, 148(7):2012-2122, 1992. |
Hartley et al., “DNA sequence selectivity of guanine-N7 alkylation by nitrogen mustards is preserved in intact cells,” Nucleic Acids Research, 20(12):3175-3178, 1992. |
Hempel et al., “Tyrosine Phosphorylation of Phospholipase C-λ2 upon Cross-linking of Membrane Ig on Murine B Lymphocytes,” The Journal of Immunology, 148(10):3021-3027, 1992. |
Jayasuriya et al., “Emodin, A Protein Tyrosine Kinase Inhibitor From Polygonum Cuspidatum,” J. Nat. Proc., 55(5):696-8, 1992. |
Hsu et al., “Inhibition Kinetics and Selectivity of the Tyrosine Kinase Inhibitor Erbstatin and a Pyridone-Based Analogue,” Biochemical Pharmacology, 43(11):2471-2477, 1992. |
Kakeya et al., “Isolation of a novel substrate-competitive tyrosine kinase inhibitor, desmal, from the plant Desmos chinensis,” FEBS, 320(2):169-172, 1993. |
Khetarpal et al., “Dispositional characteristics of a tyrosine kinase inhibitor (RG 14620) in rats and rabbits following intravenous administration or dermal application,” Drug Metabolism and Disposition, 22(2):216-223, 1994. |
Larner et al., “Tyrosine Phosphorylation of DNA Binding Proteins by Multiple Cytokines,” Science, 261:1730-1733, 1993. |
Merkel, et al., “Inhibition of EGF—Induced Vasoconstriction in Isolated Rabbit Aortic Rings with the Tyrosine Kinase Inhibitor RG50864,” Biochemical and Biophysical Research Communications,192(3):1319-1326, 1993. |
Nakamura et al., “Redox regulation of a src family protein tyrosine kinase p561ck in T cells,” Oncogene, 8:3133-3139, 1993. |
O'Connor et al., “Relationships between cdc2 Kinase, DNA Cross-linking, and Cell Cycle Perturbations Induced by Nitrogen Mustard,” Cell Growth & Differ., 3:43-52, 1992. |
Ohmichi et al., “The Tyrosine Kinase Inhibitor Tyrphostin Blocks the Cellular Actions of Nerve Growth Factor,” Biochemistry, 32:4650-4658, 1993. |
Okabe et al., “BE-23372M, A Novel Protein Tyrosine Kinase Inhibitor I. Producing Organism, Fermentation, Isolation and Biological Activities,” The Journal of Antibiotics, 47(3):289-293, 1994. |
Parker et al., “p107wee1 is a dual-specificity kinase that phosphorylates p34cdc2 on tyrosine 15,” Proc. Natl. Acad. Sci. USA, 89:2917-2921, 1992. |
Rauth et al., “The nucleotide and partial amino acid sequences of rat fetuin,” Eur. J. Biochem., 204:523-529, 1992. |
Rewcastle et al., “Tyrosine Kinase Inhibitors. 3. Structure-Activity Relationships for Inhibition of Protein Tyrosine Kinases by Nuclear-Substituted Derivatives of 2,2′-Dithiobis (1-methyl-N-phenyl-1H-indole-3-carboxamide),” J. Med. Chem., 37:2033-2042, 1994. |
Rowley et al., “Checkpoint controls in Schizosaccharomyces pombe: rad1,” The EMBO Journal, 11(4):1335-1342, 1992. |
Ruff-Jamison et al., “Induction by EGF and Interferon-λ of Tyrosine Phosphorylated DNA Binding Proteins in Mouse Liver Nuclei,” Science, 261:1733-1736, 1993. |
Smyth et al., “Non-Amine Based Analogues of Lavendustin A as a Protein-Tyrosine Kinase Inhibitors,” J. Med. Chem., 36:3010-3014, 1993. |
Smyth et al., “Hydroxylated 2-(5′-Salicyl)naphthalenes as Protein-Tyrosine Kinase Inhibitors,” J. Med. Chem., 36:3015-3020, 1993. |
Solomon et al., “Role of Phosphorylation in p37cdc2 Activation: Identification of an Activating Kinase,” Molecular Biology of the Cell, 3:13-27, 1992. |
Sugata et al., “Inhibition of Serum-Induced M-Phase Progression by a Tyrosine Kinase Inhibitor, Erbstatin,” Biochemical and Biophysical Communications, 194(1):239-245, 1993. |
Tanaka et al., “BE-23372M, A Novel Protein Tyrosine Kinase Inhibitor III. Synthesis,” Antibiot. (Tokyo), 47(3):297-300, 1994b. |
Tanaka et al., “BE23372M, A Novel Protein Tyrosine Kinase Inhibitor II. Physico-Chemical Properties and Structure Elucidation,” The Journal of Antibiotics, 47(3):294-296, 1994. |
Thakkar et al., “Synthesis and Protein-Tyrosine Kinase Inhibitory Activity of Polyhydroxylated Stilbene Analogues of Piceatannol,” J. Med. Chem., 36:2950-2955, 1993. |
Yoneda et al., “The Antiproliferative Effects of Tyrosine Kinase Inhibitors Tyrphostins on a Human Squamous Cell Carcinoma in Vitro and in Nude Mice,” Cancer Research, 51:4430-4435, 1991. |
Sherman et al., “Ionizing radidation regulates expression of the c-jun proto-oncogene,” Proc. Am. Assoc. Cancer Res., 31(0):13, 1990. |
“Cell Differentiation Inducer Contains a DNA Synthesis Inhibitor and Specified Tyrosine Kinase Inhibitor,” Derwent Publ. Ltd., 9201: Apr. 1990; “Cell Differentiation Inducer,” Patent Abstracts of Japan, 14(310):C0736, Apr. 1990. |
Ød{haeck over (ø)}m, et al., “Signal Transduction by HLA Class II Molecules in Human T Cells: Induction of LFA-1-Dependent and Independent Adhesion,” Human Immunol, 35(2):71-84, Oct. 1992. |
Hallahan, et al., “X-Ray Induced Protein Kinase C Activation Mediates Proto-Oncogene Jun Expression (Meeting Abstract),” Database Cancerlit, 830416(159):S9, Apr. 1991; “Workshop on Neoplastic Transformation In Human Cell Systems In Vitro: Mechanisms of Carcinogeneses,” p. S9, Apr. 1991. |
Darzynkiewicz, et al., “Apoptotic Mechanism Of Cell Death During Treatment of Acute Leukemias (Meeting Abstract),” Database Cancerlit, 1126890(159):164, Jul. 1993; “Molecular Biology of Hematopoiesis—8th Symposium,” p. 164, 1993. |
Uckun, et al., “Ionizing Radiation Stimulates Unidentified Tyrosine—Specific Protein Kinases In Human B-Lymphocyte Precursors, Triggering Apoptosis and Clonogenic Cell Death,” Proc. Natl. Acad. Sci. USA, 89(19):9005-9009, Oct., 1992. |